Found 1399 matching trials
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer PHASE1 This phase I trial studies the side effects and best dose of stereotactic b...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease PHASE4 Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Show More Location
Cleveland Clinic Main Campus
Learn More & Join Trial
A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01) PHASE3 This trial is a registrational Phase III, randomized, open-label, multicent...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy PHASE1 Quisinostat besides its own efficacy, which can potentially lead to better ...
Show More Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Learn More & Join Trial
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Algemeen Ziekenhuis Middelheim
Learn More & Join Trial
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies PHASE1 The purpose of this study is to test the safety of a combination of two ant...
Show More Location
Center for Lymphoid Malignancies at CUMC
Learn More & Join Trial
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments PHASE3 Comparison of olaparib vs. physician's choice of single agent standard of c...
Show More Learn More & Join Trial
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer PHASE2 This clinical trial is being conducted to determine tumor response and prel...
Show More Location
Site Reference ID/Investigator# 70538
Learn More & Join Trial
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations PHASE1 BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Show More Status
Active Not Recruiting
Location
University of Alabama
Learn More & Join Trial
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib PHASE1 The purpose of this randomized study is to determine the safety and efficac...
Show More Location
Valkyrie Clinical Trials
Learn More & Join Trial